• 113
Reading Time: 6 minutes

Most diabetic foot ulcers do not appear without warning. Before the skin breaks down, the foot often shows visible signs that tissue is under too much stress: thick plantar callus, a small blister, or a dark spot of bleeding beneath the callus. These are called pre-ulcerative lesions. In a person with diabetic peripheral neuropathy, who may feel no pain from them, they can be the only early warning that an ulcer is coming. International guidelines now treat finding and managing these lesions as a core part of ulcer prevention.

What Counts as a Pre-Ulcerative Lesion?

The International Working Group on the Diabetic Foot (IWGDF) describes pre-ulcerative signs as abundant callus, blisters, haemorrhage (bleeding into or under the skin), ingrown or thickened toenails, and fungal infection. Callus forms where the skin is repeatedly loaded, usually under the metatarsal heads, the tips of clawed or hammered toes, and the great toe. Neuropathy, foot deformity, limited joint mobility, and dry skin from autonomic nerve damage all add to the load.

These lesions are common. In the DIACET 2018 survey of more than 5,000 adults with diabetes in Tokyo, about 40% of people with type 1 diabetes and 39.5% of people with type 2 diabetes reported at least one pre-ulcerative lesion. Callus was reported by 16.8% and 10.5%, respectively. Female sex, numbness in the feet, and foot deformity were all linked to a higher chance of having these lesions (Azuma et al., 2023).

Why Callus Matters: Pressure and Hidden Damage

Callus is not just a cosmetic problem. A thick plaque of hard skin acts like a foreign body pressed into the sole: it concentrates force on a small area of soft tissue beneath it. When bleeding appears within a callus, it usually means the tissue underneath is already being damaged. In a foot without protective sensation, walking continues on that spot, and the damage can progress to an open wound hidden beneath the hard skin.

Prospective evidence supports this link. In a 12-month study of 60 people at high risk of foot ulcers, Hulshof and colleagues (2025) found that 37% developed a plantar forefoot ulcer. Having a pre-ulcer at baseline (abundant callus, haemorrhage, blister, or fissure) was strongly associated with later ulceration (odds ratio 9.97; 95% CI 1.41–70.65). The confidence interval is wide because the study was small, but the direction is clear. Walking speed also predicted ulceration. In contrast, a measure of cumulative plantar tissue stress did not predict ulcers on its own. The authors concluded that identifying and treating pre-ulcers early should help predict and prevent plantar ulcers.

What the Evidence Shows About Treatment

Callus removal

Removing callus with a scalpel (sharp debridement by a trained clinician) lowers plantar pressure. A systematic review by van Netten and colleagues (2020), done to inform IWGDF guidelines, found that callus removal reduces peak plantar pressure right after treatment. The studies it summarized reported reductions of roughly 25% to 30% in peak pressure. The review graded this evidence as low quality, because it rests on one randomized trial and two uncontrolled studies. Still, it concluded that callus removal, custom-made therapeutic footwear, and foot- and mobility-related exercises may help reduce modifiable risk factors for ulceration.

Callus tends to come back, because the forces that caused it are still there. For that reason, debridement is usually repeated at regular intervals and paired with measures that reduce load. People with neuropathy are generally advised not to cut callus or corns themselves or use chemical corn removers, because they cannot feel when they go too deep.

Addressing the cause

The van Netten review also found low-quality evidence that orthoses, such as silicone toe devices or rigid insoles, may reduce callus when worn every day. Therapeutic footwear that redistributes pressure is a central part of preventing ulcers in high-risk feet. Where a flexible hammertoe causes a pre-ulcerative lesion at the toe tip, the IWGDF 2023 guideline suggests considering a flexor tendon tenotomy. This minor procedure straightens the toe and takes load off its tip.

What the guidelines recommend

The IWGDF 2023 prevention guideline (Bus et al., 2024) recommends that people at risk be taught appropriate foot self-care, be taught not to walk without suitable foot protection, and have any pre-ulcerative lesion on the foot treated. The accompanying IWGDF practical guidelines (Schaper et al., 2024) place this inside a structured, risk-based program of regular foot examination, education, footwear, and professional foot care. More frequent review is advised for people at higher risk.

Callus also matters after an ulcer heals. As Armstrong, Boulton, and Bus (2017) explain, people whose ulcers have healed should be thought of as being in remission rather than cured, because recurrence is common. Watching for returning callus and haemorrhage at former ulcer sites is one practical way to catch relapse early.

Key Takeaways

Pre-ulcerative lesions, especially abundant callus and haemorrhage within callus, are common in people with diabetes and strongly associated with later foot ulceration. Removing callus lowers peak plantar pressure by about a quarter or more, but the effect is temporary unless the underlying load is also managed with footwear, orthoses, or, in selected cases, surgery to correct deformity. Current IWGDF guidance treats regular inspection and treatment of these lesions as a basic part of ulcer prevention, alongside education and protective footwear. The evidence base is still small and mostly low quality, and larger trials are needed to measure how much routine callus care reduces ulcer rates.

References

  • Bus SA, Sacco ICN, Monteiro-Soares M, et al. Guidelines on the prevention of foot ulcers in persons with diabetes (IWGDF 2023 update). Diabetes/Metabolism Research and Reviews. 2024;40(3):e3651.
  • Schaper NC, van Netten JJ, Apelqvist J, et al. Practical guidelines on the prevention and management of diabetes-related foot disease (IWGDF 2023 update). Diabetes/Metabolism Research and Reviews. 2024;40(3):e3657.
  • van Netten JJ, Sacco ICN, Lavery LA, et al. Treatment of modifiable risk factors for foot ulceration in persons with diabetes: a systematic review. Diabetes/Metabolism Research and Reviews. 2020;36(S1):e3271.
  • Hulshof CM, van Netten JJ, Busch-Westbroek TE, et al. The predictive value of cumulative plantar tissue stress on future plantar foot ulceration in people with diabetes: a 12-month prospective observational study. Diabetic Medicine. 2025;e70099.
  • Azuma H, Ikura K, Miura J, Babazono T. A fact-finding survey on pre-ulcerative lesions of foot in patients with diabetes: analysis using the Diabetes Study from the Center of Tokyo Women’s Medical University 2018 (DIACET 2018). Diabetology International. 2023.
  • Armstrong DG, Boulton AJM, Bus SA. Diabetic foot ulcers and their recurrence. New England Journal of Medicine. 2017;376(24):2367–2375.

Comments

comments

Author

PV Mayer

Dr. Perry Mayer is the Medical Director of The Mayer Institute (TMI), a center of excellence in the treatment of the diabetic foot. He received his undergraduate degree from Queen’s University, Kingston and medical degree from the Royal College of Surgeons in Ireland.